Pipeline

Program	Therapeutic Area	Indication	Phase 1	Phase 2	Phase 3
YA-101	Neurodegenerative Disorder	Multiple System Atrophy
YA-102	Neurodegenerative Disorder	Parkinson’s Disease
YA-201	Neurodegenerative Disorder	Alzheimer’s Disease
YA-301	Neurodevelopmental Disorder	Schizophrenia

Program

Therapeutic Area

Indication

Preclinical

Phase 1

Phase 2

Phase 3

YA-101

Neurodegenerative Disorder

YA-102

Neurodegenerative Disorder